Literature DB >> 2532134

Brain quinolinic acid in Alzheimer's dementia.

E Sofic1, J Halket, A Przyborowska, P Riederer, H Beckmann, M Sandler, K Jellinger.   

Abstract

Quinolinic acid (QA) content was measured in postmortem frontal and temporal cortex, putamen and cerebellum obtained from patients with senile dementia of Alzheimer type (SDAT), Huntington's disease (HD) and controls, using a gas chromatography/mass spectrometry method. There were no significant group differences in QA content of any of the regions examined. The data do not support the hypothesis that an accumulation of QA plays a role in neuronal degeneration occurring in the frontal and temporal cortex, putamen and cerebellum of patients with SDAT.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2532134     DOI: 10.1007/bf01739651

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Neurol Sci        ISSN: 0175-758X


  19 in total

1.  Quinolinic acid phosphoribosyltransferase in rat brain.

Authors:  A C Foster; W C Zinkand; R Schwarcz
Journal:  J Neurochem       Date:  1985-02       Impact factor: 5.372

2.  Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid.

Authors:  M F Beal; N W Kowall; D W Ellison; M F Mazurek; K J Swartz; J B Martin
Journal:  Nature       Date:  1986 May 8-14       Impact factor: 49.962

3.  Brain quinolinic acid in Huntington's disease.

Authors:  G P Reynolds; S J Pearson; J Halket; M Sandler
Journal:  J Neurochem       Date:  1988-06       Impact factor: 5.372

4.  3-Hydroxyanthranilate oxygenase activity is increased in the brains of Huntington disease victims.

Authors:  R Schwarcz; E Okuno; R J White; E D Bird; W O Whetsell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

5.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

6.  Excitotoxic models for neurodegenerative disorders.

Authors:  R Schwarcz; A C Foster; E D French; W O Whetsell; C Köhler
Journal:  Life Sci       Date:  1984-07-02       Impact factor: 5.037

7.  Identification of quinolinic acid in rat and human brain tissue.

Authors:  M Wolfensberger; U Amsler; M Cuénod; A C Foster; W O Whetsell; R Schwarcz
Journal:  Neurosci Lett       Date:  1983-11-11       Impact factor: 3.046

8.  Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain.

Authors:  R Schwarcz; W O Whetsell; R M Mangano
Journal:  Science       Date:  1983-01-21       Impact factor: 47.728

9.  Some morphometric aspects of the brain in senile dementia of the Alzheimer type.

Authors:  R D Terry; A Peck; R DeTeresa; R Schechter; D S Horoupian
Journal:  Ann Neurol       Date:  1981-08       Impact factor: 10.422

10.  Increase in the content of quinolinic acid in cerebrospinal fluid and frontal cortex of patients with hepatic failure.

Authors:  F Moroni; G Lombardi; V Carlà; S Lal; P Etienne; N P Nair
Journal:  J Neurochem       Date:  1986-12       Impact factor: 5.372

View more
  3 in total

Review 1.  Kynurenines and intestinal neurotransmission: the role of N-methyl-D-aspartate receptors.

Authors:  József Kaszaki; Dániel Erces; Gabriella Varga; Andrea Szabó; László Vécsei; Mihály Boros
Journal:  J Neural Transm (Vienna)       Date:  2011-05-27       Impact factor: 3.575

Review 2.  Kynurenines, neurodegeneration and Alzheimer's disease.

Authors:  Zsigmond Tamas Kincses; József Toldi; László Vécsei
Journal:  J Cell Mol Med       Date:  2010-07-12       Impact factor: 5.310

Review 3.  Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development.

Authors:  Knut Biber; Anindya Bhattacharya; Brian M Campbell; Justin R Piro; Michael Rohe; Roland G W Staal; Robert V Talanian; Thomas Möller
Journal:  Front Pharmacol       Date:  2019-08-23       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.